SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-11-000071
Filing Date
2011-01-18
Accepted
2011-01-18 08:55:14
Documents
4
Period of Report
2010-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 16489
2 Q2 INTERIM FINANCIAL STATEMENTS ex991.htm EX-99.1 509175
3 Q2 MANAGEMENT'S DISCUSSION AND ANALYSIS ex992.htm EX-99.2 180176
4 CEO AND CFO CERTIFICATIONS ex993.htm EX-99.3 28287
  Complete submission text file 0001279569-11-000071.txt   735778
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 11531833
SIC: 2836 Biological Products, (No Diagnostic Substances)